ZNF683
gene geneOn this page
Also known as MGC33414Hobit
Summary
ZNF683 (zinc finger protein 683, HGNC:28495) is a protein-coding gene on chromosome 1p36.11, encoding Tissue-resident T-cell transcription regulator protein ZNF683 (Q8IZ20). Transcription factor that mediates a transcriptional program in various innate and adaptive immune tissue-resident lymphocyte T-cell types such as tissue-resident memory T (Trm), natural killer (trNK) and natural killer T (NKT) cells and negatively regulates gene expression of p….
Enables RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in T cell receptor signaling pathway; cellular response to ionomycin; and regulation of gene expression. Predicted to be located in nucleus.
Source: NCBI Gene 257101 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 94 total
- MANE Select transcript:
NM_001114759
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28495 |
| Approved symbol | ZNF683 |
| Name | zinc finger protein 683 |
| Location | 1p36.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33414, Hobit |
| Ensembl gene | ENSG00000176083 |
| Ensembl biotype | protein_coding |
| OMIM | 616775 |
| Entrez | 257101 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 13 protein_coding
ENST00000349618, ENST00000403843, ENST00000416125, ENST00000423508, ENST00000436292, ENST00000451801, ENST00000453132, ENST00000454975, ENST00000455900, ENST00000897146, ENST00000897147, ENST00000897148, ENST00000897149
RefSeq mRNA: 3 — MANE Select: NM_001114759
NM_001114759, NM_001307925, NM_173574
CCDS: CCDS279, CCDS76126
Canonical transcript exons
ENST00000349618 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001230976 | 26367593 | 26367797 |
| ENSE00001337229 | 26368458 | 26368585 |
| ENSE00001549666 | 26361634 | 26362022 |
| ENSE00001672510 | 26363026 | 26363154 |
| ENSE00001743360 | 26364532 | 26365226 |
| ENSE00003901552 | 26372669 | 26372750 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 94.37.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.0156 / max 197.0256, expressed in 97 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 11174 | 0.6246 | 81 |
| 11173 | 0.2803 | 43 |
| 11172 | 0.0432 | 17 |
| 11175 | 0.0426 | 3 |
| 11176 | 0.0165 | 3 |
| 201419 | 0.0044 | 3 |
| 11177 | 0.0040 | 3 |
Top tissues by expression
221 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 94.37 | gold quality |
| left testis | UBERON:0004533 | 94.33 | gold quality |
| right testis | UBERON:0004534 | 94.09 | gold quality |
| granulocyte | CL:0000094 | 93.09 | gold quality |
| testis | UBERON:0000473 | 91.13 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.07 | gold quality |
| parotid gland | UBERON:0001831 | 82.98 | silver quality |
| vena cava | UBERON:0004087 | 82.65 | gold quality |
| heart right ventricle | UBERON:0002080 | 81.98 | silver quality |
| upper arm skin | UBERON:0004263 | 81.86 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 80.44 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 80.39 | gold quality |
| pancreatic ductal cell | CL:0002079 | 78.57 | silver quality |
| adult organism | UBERON:0007023 | 78.38 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 78.01 | silver quality |
| trabecular bone tissue | UBERON:0002483 | 77.90 | silver quality |
| body of tongue | UBERON:0011876 | 77.24 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 77.02 | silver quality |
| pons | UBERON:0000988 | 76.37 | silver quality |
| lateral globus pallidus | UBERON:0002476 | 76.30 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 76.15 | gold quality |
| cerebellar vermis | UBERON:0004720 | 75.78 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 75.44 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 74.62 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 74.47 | silver quality |
| blood | UBERON:0000178 | 74.22 | gold quality |
| right uterine tube | UBERON:0001302 | 74.11 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 73.72 | silver quality |
| pylorus | UBERON:0001166 | 73.69 | silver quality |
| cardia of stomach | UBERON:0001162 | 73.30 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8911 | yes | 591.56 |
| E-ANND-3 | no | 2.18 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2522.1 | ZNF683 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
Literature-anchored findings (GeneRIF, showing 7)
- These data implicate Hobit as a novel transcriptional regulator in quiescent human effector-type CD8(+) T cells that regulates their immediate effector functions. (PMID:26179882)
- Hobit’s function in human T cells is highly adapted to lifelong, periodic challenges with varying, physiological doses of pathogens. (PMID:26440905)
- Transcription factor Hobit identifies a subset of NK cells in Human livers that express a distinct set of adhesion molecules and chemokine receptors consistent with tissue residency. These data suggest that Hobit is involved in regulating tissue-residency of human intrahepatic CD56bright NK cells in a subset of NK cells in inflamed livers. (PMID:28751776)
- These findings suggest that Blimp-1 initiates cytotoxic effector function and that Hobit maintains cytotoxicity in a deployment-ready modus in tissue-resident memory CD8 T cells. (PMID:30051906)
- Transcription Factor ZNF683 Inhibits SIV/HIV Replication through Regulating IFNgamma Secretion of CD8+ T Cells. (PMID:35458449)
- Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. (PMID:36245253)
- Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer. (PMID:36869093)
Cross-species orthologs
0 orthologs
Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Tissue-resident T-cell transcription regulator protein ZNF683 — Q8IZ20 (reviewed: Q8IZ20)
Alternative names: Homolog of Blimp-1 in T-cell, Zinc finger protein 683
All UniProt accessions (7): A0A0A0MSJ7, A0A0A0MT21, Q8IZ20, Q5T142, Q5T145, X1WI31, X1WI32
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor that mediates a transcriptional program in various innate and adaptive immune tissue-resident lymphocyte T-cell types such as tissue-resident memory T (Trm), natural killer (trNK) and natural killer T (NKT) cells and negatively regulates gene expression of proteins that promote the egress of tissue-resident T-cell populations from non-lymphoid organs. Plays a role in the development, retention and long-term establishment of adaptive and innate tissue-resident lymphocyte T cell types in non-lymphoid organs, such as the skin and gut, but also in other nonbarrier tissues like liver and kidney, and therefore may provide immediate immunological protection against reactivating infections or viral reinfection. Also plays a role in the differentiation of both thymic and peripheral NKT cells. Negatively regulates the accumulation of interferon-gamma (IFN-gamma) in NKT cells at steady state or after antigenic stimulation. Positively regulates granzyme B production in NKT cells after innate stimulation. Associates with the transcriptional repressor PRDM1/BLIMP1 to chromatin at gene promoter regions. Lacks transcriptional repressor activity. Binds to DNA within promoter regions of the transcriptional repressor PRDM1/BLIMP1 target sites. Unable to regulate interferon-gamma (IFN-gamma) production in cytomegalovirus (CMV)-infected effector CD8(+) T-cells. Transcriptional repressor that binds to DNA within promoter regions of the transcriptional repressor PRDM1/BLIMP1 target sites. Regulates interferon-gamma (IFN-gamma) production in cytomegalovirus (CMV)-infected effector CD8(+) T cells.
Subcellular location. Nucleus.
Tissue specificity. Expressed in terminally differentiated effector CD8(+) T-cells, but not in naive and central memory cells. Expressed in terminally differentiated natural killer (NK) cells and natural killer (NKT) T-cells (at protein level). Expressed strongly in effector-type CD8(+) T-cells and weakly in naive and memory CD8(+) T-cells. Expressed in terminally differentiated natural killer (NK) cells. Isoform 2 is strongly expressed in effector CD8(+) T and natural killer (NK) cells. Isoform 1 is expressed in effector CD8(+) T and natural killer (NK) cells. (Microbial infection) Expressed in cytomegalovirus (CMV)-infected effector CD8(+) T-cells (at protein level).
Domain organisation. The C2H2-type zinc finger are necessary for DNA-binding.
Induction. (Microbial infection) Up-regulated by cytomegalovirus (CMV) infection in long-lived effector CD8(+) T-cells.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IZ20-1 | 1, Extra large, XL | yes |
| Q8IZ20-2 | 2, Large, L |
RefSeq proteins (3): NP_001108231, NP_001294854, NP_775845 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050331 | Zinc_finger_PRDM4/PRDM1/PRDM14 | Family |
Pfam: PF00096
UniProt features (14 total): sequence variant 5, zinc finger region 4, region of interest 2, chain 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IZ20-F1 | 50.04 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 96 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE, GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_REGULATION_OF_HEMOPOIESIS, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION, GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION
GO Biological Process (16): negative regulation of transcription by RNA polymerase II (GO:0000122), adaptive immune response (GO:0002250), regulation of transcription by RNA polymerase II (GO:0006357), regulation of gene expression (GO:0010468), positive regulation of gene expression (GO:0010628), negative regulation of type II interferon production (GO:0032689), regulation of natural killer cell differentiation (GO:0032823), obsolete regulation of natural killer cell differentiation involved in immune response (GO:0032826), regulation of extrathymic T cell differentiation (GO:0033082), innate immune response (GO:0045087), T cell receptor signaling pathway (GO:0050852), regulation of NK T cell differentiation (GO:0051136), cellular response to ionomycin (GO:1904637), immune system process (GO:0002376), regulation of immune system process (GO:0002682), regulation of multicellular organismal process (GO:0051239)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), promoter-specific chromatin binding (GO:1990841), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| immune response | 2 |
| regulation of DNA-templated transcription | 2 |
| gene expression | 2 |
| regulation of biological process | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| regulation of gene expression | 1 |
| positive regulation of macromolecule biosynthetic process | 1 |
| negative regulation of cytokine production | 1 |
| type II interferon production | 1 |
| regulation of type II interferon production | 1 |
| natural killer cell differentiation | 1 |
| regulation of natural killer cell activation | 1 |
| regulation of lymphocyte differentiation | 1 |
| extrathymic T cell differentiation | 1 |
| regulation of T cell differentiation | 1 |
| defense response to symbiont | 1 |
| antigen receptor-mediated signaling pathway | 1 |
| NK T cell differentiation | 1 |
| regulation of alpha-beta T cell differentiation | 1 |
| cellular response to ether | 1 |
| cellular response to fatty acid | 1 |
| response to ionomycin | 1 |
| biological_process | 1 |
| immune system process | 1 |
| multicellular organismal process | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| chromatin binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
568 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF683 | EOMES | O95936 | 608 |
| ZNF683 | ITGAE | P38570 | 607 |
| ZNF683 | ITGA1 | P56199 | 606 |
| ZNF683 | RUNX3 | Q13761 | 595 |
| ZNF683 | S1PR1 | P21453 | 592 |
| ZNF683 | TBX21 | Q9UL17 | 580 |
| ZNF683 | CD69 | Q07108 | 577 |
| ZNF683 | KLRD1 | Q13241 | 554 |
| ZNF683 | CXCR6 | O00574 | 546 |
| ZNF683 | KLRK1 | P26718 | 524 |
| ZNF683 | GZMK | P49863 | 513 |
| ZNF683 | PRDM1 | O75626 | 512 |
| ZNF683 | CCR7 | P32248 | 507 |
| ZNF683 | CD8A | P01732 | 507 |
| ZNF683 | CRTAM | O95727 | 490 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CYSRT1 | ZNF683 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF683 | ZNF330 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR20D | ZNF683 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF683 | RHOXF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-2 | ZNF683 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF683 | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF330 | ZNF683 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRR20D | ZNF683 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RHOXF2 | ZNF683 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF683 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): ZNF683 (Two-hybrid), ZNF683 (Two-hybrid), KRTAP6-2 (Two-hybrid), CYSRT1 (Two-hybrid), PRR20B (Two-hybrid), PRR20A (Two-hybrid), PRR20D (Two-hybrid), PRR20C (Two-hybrid), PRR20E (Two-hybrid)
ESM2 similar proteins: A0A5F9ZHS7, A1YGK1, A2T7E6, A8MZG2, O08574, O43593, O60393, O75593, O88621, O95231, P0C1T1, P0CG20, P20428, P97609, Q04667, Q17QR5, Q2KIS6, Q2M1V0, Q2T9Q7, Q32LE6, Q497V6, Q5JUK2, Q5M844, Q5RJB0, Q5TGS1, Q61645, Q61657, Q6ZMY3, Q6ZN32, Q6ZNG2, Q7RTU1, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8N1L9, Q8N7G0, Q8N944, Q8N9Y4
Diamond homologs: I7HJS4, O75626, Q60636, Q8IZ20, Q93560, A0A163UT06, A2AGX3, A2AJ77, A2BID7, A6QPM3, B4F6U4, E9Q3T6, E9Q8T2, P0C6Y7, P57071, Q13029, Q3UTQ7, Q3UZD5, Q5R5M1, Q5RAX9, Q63755, Q80V63, Q96EQ9, Q9CXE0, Q9GZV8, Q9H4Q4, Q9NQV5, Q9NQV6, Q9NQV7, Q9NQW5, Q9NQX0, Q9NQX1, Q9QZP2, Q9UKN5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
94 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1368 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:26367591:A:AC | donor_gain | 1.0000 |
| 1:26367592:C:CC | donor_gain | 1.0000 |
| 1:26367592:CT:C | donor_gain | 1.0000 |
| 1:26362020:CAC:C | acceptor_gain | 0.9900 |
| 1:26362021:ACC:A | acceptor_loss | 0.9900 |
| 1:26362022:CCT:C | acceptor_loss | 0.9900 |
| 1:26362023:CTGA:C | acceptor_loss | 0.9900 |
| 1:26362024:T:G | acceptor_loss | 0.9900 |
| 1:26365115:C:CA | donor_gain | 0.9900 |
| 1:26372667:A:AC | donor_gain | 0.9900 |
| 1:26372668:C:CC | donor_gain | 0.9900 |
| 1:26372668:CT:C | donor_gain | 0.9900 |
| 1:26372687:T:A | donor_gain | 0.9900 |
| 1:26362018:CACAC:C | acceptor_gain | 0.9800 |
| 1:26363019:ATCTC:A | donor_loss | 0.9800 |
| 1:26363020:TCTCA:T | donor_loss | 0.9800 |
| 1:26363021:CTCA:C | donor_loss | 0.9800 |
| 1:26363022:TCACC:T | donor_loss | 0.9800 |
| 1:26363023:CACCG:C | donor_loss | 0.9800 |
| 1:26363024:A:T | donor_loss | 0.9800 |
| 1:26364527:GATA:G | donor_loss | 0.9800 |
| 1:26364528:ATAC:A | donor_loss | 0.9800 |
| 1:26364529:TA:T | donor_loss | 0.9800 |
| 1:26364530:ACC:A | donor_loss | 0.9800 |
| 1:26364531:C:CA | donor_loss | 0.9800 |
| 1:26364562:G:A | donor_gain | 0.9800 |
| 1:26365054:T:A | donor_gain | 0.9800 |
| 1:26365120:G:A | donor_gain | 0.9800 |
| 1:26365146:G:C | donor_gain | 0.9800 |
| 1:26365151:T:TA | donor_gain | 0.9800 |
AlphaMissense
3280 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:26362005:G:C | F407L | 0.999 |
| 1:26362005:G:T | F407L | 0.999 |
| 1:26362007:A:G | F407L | 0.999 |
| 1:26363075:A:G | L365P | 0.999 |
| 1:26363092:G:C | F359L | 0.999 |
| 1:26363092:G:T | F359L | 0.999 |
| 1:26363094:A:G | F359L | 0.999 |
| 1:26364553:A:C | F331L | 0.999 |
| 1:26364553:A:T | F331L | 0.999 |
| 1:26364555:A:G | F331L | 0.999 |
| 1:26364576:A:G | C324R | 0.999 |
| 1:26361921:G:C | F435L | 0.998 |
| 1:26361921:G:T | F435L | 0.998 |
| 1:26361923:A:G | F435L | 0.998 |
| 1:26362006:A:G | F407S | 0.998 |
| 1:26363067:G:C | H368D | 0.998 |
| 1:26363093:A:G | F359S | 0.998 |
| 1:26363104:G:C | C355W | 0.998 |
| 1:26363106:A:G | C355R | 0.998 |
| 1:26363115:A:G | C352R | 0.998 |
| 1:26363119:G:C | F350L | 0.998 |
| 1:26363119:G:T | F350L | 0.998 |
| 1:26363121:A:G | F350L | 0.998 |
| 1:26363147:A:G | L341P | 0.998 |
| 1:26364536:A:G | L337P | 0.998 |
| 1:26364565:A:C | C327W | 0.998 |
| 1:26364566:C:G | C327S | 0.998 |
| 1:26364566:C:T | C327Y | 0.998 |
| 1:26364567:A:G | C327R | 0.998 |
| 1:26364567:A:T | C327S | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000083207 (1:26373586 C>G), RS1000148673 (1:26361615 C>T), RS1000178584 (1:26366271 G>A), RS1000357740 (1:26372420 A>G), RS1000834320 (1:26371959 C>T), RS1000992854 (1:26361170 C>A), RS1001145081 (1:26366800 C>T), RS1001252855 (1:26364467 G>C), RS1001435913 (1:26370570 C>G), RS1001643707 (1:26371004 C>T), RS1001867751 (1:26363685 T>C), RS1001926782 (1:26370032 G>A), RS1002082844 (1:26375464 C>A), RS1002719579 (1:26363533 C>T), RS1003157382 (1:26363922 T>A,C)
Disease associations
OMIM: gene MIM:616775 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases mutagenesis | 2 |
| GSK-J4 | decreases expression | 1 |
| butylbenzyl phthalate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Amiodarone | increases expression | 1 |
| Testosterone | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.